$ACAN
AmeriCann, Inc.

2020 Q4 Form 10-Q Financial Statement

#000143774921002979 Filed on February 16, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4
Revenue $271.6K $34.69K
YoY Change 682.87%
Cost Of Revenue $7.500K
YoY Change
Gross Profit $264.1K
YoY Change
Gross Profit Margin 97.24%
Selling, General & Admin $574.2K -$1.183M
YoY Change -148.55% -327.6%
% of Gross Profit 217.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $112.6K $108.6K
YoY Change 3.75% 23448.37%
% of Gross Profit 42.65%
Operating Expenses $566.7K -$1.183M
YoY Change -147.92% -430.42%
Operating Profit -$302.6K $1.217M
YoY Change -124.86% -440.12%
Interest Expense -$199.7K -$199.3K
YoY Change 0.2% -231.65%
% of Operating Profit -16.37%
Other Income/Expense, Net -$199.7K -$199.3K
YoY Change 0.2% 10.35%
Pretax Income -$502.3K $1.018M
YoY Change -149.34% -282.79%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$502.3K $1.018M
YoY Change -149.34% -289.04%
Net Earnings / Revenue -184.95% 2934.44%
Basic Earnings Per Share
Diluted Earnings Per Share -$21.20K $43.31K
COMMON SHARES
Basic Shares Outstanding 23.70M 23.50M
Diluted Shares Outstanding 23.70M 23.50M

Balance Sheet

Concept 2020 Q4 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $448.3K $62.08K
YoY Change 622.07% -13.56%
Cash & Equivalents $448.3K $62.08K
Short-Term Investments
Other Short-Term Assets $13.09K $358.7K
YoY Change -96.35% -92.03%
Inventory
Prepaid Expenses
Receivables $140.8K $1.520K
Other Receivables $38.75K $1.787M
Total Short-Term Assets $640.9K $2.209M
YoY Change -70.99% -51.94%
LONG-TERM ASSETS
Property, Plant & Equipment $7.400M $7.662M
YoY Change -3.42% 332582.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.110K
YoY Change -99.89%
Total Long-Term Assets $14.37M $14.85M
YoY Change -3.24% 177.41%
TOTAL ASSETS
Total Short-Term Assets $640.9K $2.209M
Total Long-Term Assets $14.37M $14.85M
Total Assets $15.01M $17.06M
YoY Change -12.01% 71.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $85.00K $129.4K
YoY Change -34.32% 117.02%
Accrued Expenses $89.23K $104.5K
YoY Change -14.65% 134.97%
Deferred Revenue
YoY Change
Short-Term Debt $301.0K $385.0K
YoY Change -21.82% -37.4%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $818.0K $626.0K
YoY Change 30.67% -74.97%
LONG-TERM LIABILITIES
Long-Term Debt $4.578M $4.951M
YoY Change -7.53%
Other Long-Term Liabilities $4.243M $4.246M
YoY Change -0.06%
Total Long-Term Liabilities $8.822M $9.197M
YoY Change -4.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $818.0K $626.0K
Total Long-Term Liabilities $8.822M $9.197M
Total Liabilities $9.640M $9.823M
YoY Change -1.87% 292.74%
SHAREHOLDERS EQUITY
Retained Earnings -$19.22M -$18.72M
YoY Change 2.68% 37.18%
Common Stock $2.370K $2.351K
YoY Change 0.81% 3.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.371M $7.237M
YoY Change
Total Liabilities & Shareholders Equity $15.01M $17.06M
YoY Change -12.01% 71.45%

Cashflow Statement

Concept 2020 Q4 2019 Q4
OPERATING ACTIVITIES
Net Income -$502.3K $1.018M
YoY Change -149.34% -289.04%
Depreciation, Depletion And Amortization $112.6K $108.6K
YoY Change 3.75% 23448.37%
Cash From Operating Activities -$242.4K -$603.5K
YoY Change -59.83% 12.94%
INVESTING ACTIVITIES
Capital Expenditures -$305.0K
YoY Change 1041.11%
Acquisitions
YoY Change
Other Investing Activities $8.120K $4.810K
YoY Change 68.81% -14.11%
Cash From Investing Activities $8.117K -$300.2K
YoY Change -102.7% 1320.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $500.0K
YoY Change
NET CHANGE
Cash From Operating Activities -$242.4K -603.5K
Cash From Investing Activities $8.117K -300.2K
Cash From Financing Activities $500.0K
Net Change In Cash $265.7K -903.8K
YoY Change -129.4% -284.46%
FREE CASH FLOW
Cash From Operating Activities -$242.4K -$603.5K
Capital Expenditures -$305.0K
Free Cash Flow -$298.5K
YoY Change -41.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 acan Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
26246
CY2020Q4 acan Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
8911650
CY2020Q4 acan Class Of Warrant Or Right Exercisable Exercise Price
ClassOfWarrantOrRightExercisableExercisePrice
1.26
CY2020Q4 acan Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm
P1Y146D
CY2020Q4 acan Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
727000
CY2020Q4 acan Class Of Warrant Or Right Expired During Period Exercise Price
ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice
3
CY2020 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P1Y182D
CY2020Q4 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P1Y146D
CY2020Q4 acan Increase Decrease In Interest Payable Related Party Net
IncreaseDecreaseInInterestPayableRelatedPartyNet
13194
CY2019Q4 acan Increase Decrease In Interest Payable Related Party Net
IncreaseDecreaseInInterestPayableRelatedPartyNet
1144
CY2020Q4 acan Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2341
CY2019Q4 acan Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2164
CY2020Q4 acan Increase Decrease In Tenant Receivable
IncreaseDecreaseInTenantReceivable
16174
CY2019Q4 acan Increase Decrease In Tenant Receivable
IncreaseDecreaseInTenantReceivable
-14458
CY2020Q4 acan Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
39440
CY2020Q4 acan Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
14001500
CY2020Q4 acan Notes And Other Receivables Net
NotesAndOtherReceivablesNet
111395
CY2020Q3 acan Notes And Other Receivables Net
NotesAndOtherReceivablesNet
119512
CY2020Q4 acan Notes And Other Receivables Net Current
NotesAndOtherReceivablesNetCurrent
38753
CY2020Q3 acan Notes And Other Receivables Net Current
NotesAndOtherReceivablesNetCurrent
37165
CY2020Q4 acan Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
85375
CY2020Q4 acan Operating Lease Rightofuse Asset Amortization Expense
OperatingLeaseRightofuseAssetAmortizationExpense
16830
CY2019Q4 acan Operating Lease Rightofuse Asset Amortization Expense
OperatingLeaseRightofuseAssetAmortizationExpense
16655
CY2014Q1 acan Ownership Percentage Transfered
OwnershipPercentageTransfered
0.93
CY2020Q4 acan Payments To Acquire Property Plant And Equipment Excluding Construction In Progress
PaymentsToAcquirePropertyPlantAndEquipmentExcludingConstructionInProgress
CY2019Q4 acan Payments To Acquire Property Plant And Equipment Excluding Construction In Progress
PaymentsToAcquirePropertyPlantAndEquipmentExcludingConstructionInProgress
197442
CY2020Q4 acan Tenant Receivable Current
TenantReceivableCurrent
140791
CY2020Q3 acan Tenant Receivable Current
TenantReceivableCurrent
124617
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
337553
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
276155
CY2020Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
85000
CY2020Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
65000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
560639
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
448006
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24593485
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24593485
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
108522
CY2020Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
68938
CY2019Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
77332
CY2020Q4 us-gaap Assets
Assets
15010577
CY2020Q3 us-gaap Assets
Assets
14866289
CY2020Q4 us-gaap Assets Current
AssetsCurrent
640897
CY2020Q3 us-gaap Assets Current
AssetsCurrent
357441
CY2020Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.39
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.26
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
9638650
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8911650
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Depreciation
Depreciation
108558
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
112633
CY2019Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
108558
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.04
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
448263
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
183009
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
458853
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
193159
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1292062
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
388300
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
265694
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-903762
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23696310
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23696310
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23696310
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23696310
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2370
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
2370
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
503295
CY2020Q3 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
571483
CY2020Q4 us-gaap Depreciation
Depreciation
112633
CY2019Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
103666
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4256869
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4245611
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2387
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4728
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4243224
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
475881
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
456348
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2019Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2020Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
61398
CY2019Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-135868
CY2020Q4 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
20000
CY2019Q4 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
CY2020Q4 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
758
CY2019Q4 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-27582
CY2020Q4 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-15375
CY2019Q4 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-2098
CY2020Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
CY2019Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
18815
CY2020Q4 us-gaap Interest Expense Other
InterestExpenseOther
191659
CY2019Q4 us-gaap Interest Expense Other
InterestExpenseOther
159449
CY2020Q4 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
13195
CY2019Q4 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
39849
CY2020Q4 us-gaap Interest Paid Net
InterestPaidNet
121964
CY2019Q4 us-gaap Interest Paid Net
InterestPaidNet
77470
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
86847
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
72895
CY2020Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
5148
CY2019Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
CY2020Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.079
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-199706
CY2019Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-199298
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15623625
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
341500
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
341500
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
341500
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
341500
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
256125
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11378014
CY2020Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P45Y273D
CY2020Q4 us-gaap Liabilities
Liabilities
9639558
CY2020Q3 us-gaap Liabilities
Liabilities
8992986
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15010577
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14866289
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
817983
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
589599
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
3996705
CY2020Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
3578517
CY2020Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1426
CY2019Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
36126
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
500000
CY2019Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8117
CY2019Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-300214
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-242423
CY2019Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-603548
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-502284
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
1017985
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
301000
CY2020Q3 us-gaap Notes Payable Current
NotesPayableCurrent
150250
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
581646
CY2020Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
581646
CY2020Q4 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
38753
CY2020Q3 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
37165
CY2020Q4 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
72642
CY2020Q3 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
82347
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
574163
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
-1182592
CY2020Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
107365
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-302578
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1217283
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4243224
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6980957
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6897250
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6914080
CY2020Q4 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
271585
CY2019Q4 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
34691
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5196
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20571
CY2020Q4 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
CY2019Q4 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
107579
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2500
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2500
CY2020Q4 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
8117
CY2019Q4 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
4807
CY2020Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
500000
CY2019Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
CY2020Q4 us-gaap Professional Fees
ProfessionalFees
96856
CY2019Q4 us-gaap Professional Fees
ProfessionalFees
86609
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7960427
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7960427
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7399788
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7512421
CY2020Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2019Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1761675
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10590
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10150
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19224836
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18722552
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18722552
CY2020Q4 us-gaap Revenues
Revenues
271585
CY2019Q4 us-gaap Revenues
Revenues
34691
CY2020Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6980957
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
CY2019Q4 us-gaap Share Based Compensation
ShareBasedCompensation
108522
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1850000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.99
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1850000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1850000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.99
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.99
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1850000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.99
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y73D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5371019
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5873303
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
6110676
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
7237183
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23696310
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23504820
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23696310
CY2019Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23504820
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23696310
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23504820

Files In Submission

Name View Source Status
0001437749-21-002979-index-headers.html Edgar Link pending
0001437749-21-002979-index.html Edgar Link pending
0001437749-21-002979.txt Edgar Link pending
0001437749-21-002979-xbrl.zip Edgar Link pending
acan-20201231.xml Edgar Link completed
acan-20201231.xsd Edgar Link pending
acan-20201231_cal.xml Edgar Link unprocessable
acan-20201231_def.xml Edgar Link unprocessable
acan-20201231_lab.xml Edgar Link unprocessable
acan-20201231_pre.xml Edgar Link unprocessable
acan20201231_10q.htm Edgar Link pending
ex_224624.htm Edgar Link pending
ex_224625.htm Edgar Link pending
ex_224626.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending